Meclizine Hydrochloride

ADVERTISEMENT

Identification

Molecular formula
C21H25ClN2O3
CAS Number
31884-14-5
IUPAC Name
1-[3-methoxy-4-[4-(4-phenylpiperazin-1-yl)butoxy]phenyl]ethanone;hydrochloride
Molecular Weight
450.99g/mol
Melting Point
(Celsius)
Boiling Point
(Celsius)
Density
0.9876g/cm3
Synonyms
Su 14542
Interesting facts

Interesting Facts about 1-[3-methoxy-4-[4-(4-phenylpiperazin-1-yl)butoxy]phenyl]ethanone;hydrochloride

This compound, commonly referred to simply as a halogenated derivative in the context of medicinal chemistry, is notable for its application as a potential therapeutic agent. It belongs to a class of molecules that are increasingly being explored for their neuropharmacological properties. Here are some intriguing insights:

  • Medicinal Properties: This compound is being studied for its potential mechanism of action on neurotransmitter systems, particularly in relation to conditions such as anxiety and depression.
  • Structural Complexity: The structure of the compound features a unique blend of a phenylpiperazine moiety, which is known for enhancing binding to serotonin receptors, and an ether component, increasing its lipophilicity.
  • Research Significance: As a part of ongoing research, derivatives like this one are essential for developing new therapies. The ability to manipulate the chemical structure can lead to compounds with improved efficacy and reduced side effects.
  • Pharmacological Exploration: The compound's interaction with various receptors in the brain has made it a focal point in studies related to antipsychotic medications and their mechanisms.
  • Potential for Synthesis Innovations: Organic synthesis techniques applied to compounds like this can provide new insights into modification strategies, leading to analogs with distinct biological activity.

As the understanding of brain chemistry evolves, compounds like this represent the frontier of research where chemistry meets pharmacology, and where understanding structure-activity relationships can lead to groundbreaking therapeutic developments. In the words of renowned chemist Linus Pauling, "The best way to have a good idea is to have a lot of ideas." This sentiment rings true as researchers continue to explore the vast potentials inherent in structural diversity!

ADVERTISEMENT